 | • レポートコード：GIR-107A12853 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アクティブ経皮薬物供給装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アクティブ経皮薬物供給装置の種類別市場規模（パッチ、ジェル）、用途別市場規模（クリニック、病院、家庭用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アクティブ経皮薬物供給装置の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis AG、Noven Pharmaceuticals, Inc.、Transdermal Corp.、Johnson & Johnson (Janssen Pharmaceuticals Inc.)、Mylan N.V.、3M、Actavis, Inc.、Bayer AG、Boehringer Ingelheim GmbH、Corium International, Inc.、Echo Therapeutics, Inc.、GlaxoSmithKline plc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：パッチ、ジェル ・用途別分析2016年-2026年：クリニック、病院、家庭用 ・アクティブ経皮薬物供給装置の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アクティブ経皮薬物供給装置のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アクティブ経皮薬物供給装置のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アクティブ経皮薬物供給装置の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アクティブ経皮薬物供給装置の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Active Transdermal Drug Delivery Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Active Transdermal Drug Delivery Device size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Active Transdermal Drug Delivery Device market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Active Transdermal Drug Delivery Device market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Patches
Gels
Market segment by Application can be divided into
Clinic
Hospital
Home Use
The key market players for global Active Transdermal Drug Delivery Device market are listed below:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Active Transdermal Drug Delivery Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Transdermal Drug Delivery Device, with price, sales, revenue and global market share of Active Transdermal Drug Delivery Device from 2019 to 2021.
Chapter 3, the Active Transdermal Drug Delivery Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Transdermal Drug Delivery Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Active Transdermal Drug Delivery Device market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Active Transdermal Drug Delivery Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Active Transdermal Drug Delivery Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Transdermal Drug Delivery Device Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Patches
1.2.3 Gels
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Transdermal Drug Delivery Device Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Active Transdermal Drug Delivery Device Market Size & Forecast
1.4.1 Global Active Transdermal Drug Delivery Device Sales in Value (2016-2026))
1.4.2 Global Active Transdermal Drug Delivery Device Sales in Volume (2016-2026)
1.4.3 Global Active Transdermal Drug Delivery Device Price by Type (2016-2026) & (USD/Unit)
1.5 Global Active Transdermal Drug Delivery Device Production Capacity Analysis
1.5.1 Global Active Transdermal Drug Delivery Device Total Production Capacity (2016-2026)
1.5.2 Global Active Transdermal Drug Delivery Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Active Transdermal Drug Delivery Device Market Drivers
1.6.2 Active Transdermal Drug Delivery Device Market Restraints
1.6.3 Active Transdermal Drug Delivery Device Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Active Transdermal Drug Delivery Device Product and Services
2.1.4 Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Noven Pharmaceuticals, Inc.
2.2.1 Noven Pharmaceuticals, Inc. Details
2.2.2 Noven Pharmaceuticals, Inc. Major Business
2.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product and Services
2.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Transdermal Corp.
2.3.1 Transdermal Corp. Details
2.3.2 Transdermal Corp. Major Business
2.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Product and Services
2.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
2.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Details
2.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business
2.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product and Services
2.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Mylan N.V.
2.5.1 Mylan N.V. Details
2.5.2 Mylan N.V. Major Business
2.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Product and Services
2.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 3M
2.6.1 3M Details
2.6.2 3M Major Business
2.6.3 3M Active Transdermal Drug Delivery Device Product and Services
2.6.4 3M Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Actavis, Inc.
2.7.1 Actavis, Inc. Details
2.7.2 Actavis, Inc. Major Business
2.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Product and Services
2.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business
2.8.3 Bayer AG Active Transdermal Drug Delivery Device Product and Services
2.8.4 Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Boehringer Ingelheim GmbH
2.9.1 Boehringer Ingelheim GmbH Details
2.9.2 Boehringer Ingelheim GmbH Major Business
2.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product and Services
2.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Corium International, Inc.
2.10.1 Corium International, Inc. Details
2.10.2 Corium International, Inc. Major Business
2.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Product and Services
2.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Echo Therapeutics, Inc.
2.11.1 Echo Therapeutics, Inc. Details
2.11.2 Echo Therapeutics, Inc. Major Business
2.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product and Services
2.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business
2.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product and Services
2.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Active Transdermal Drug Delivery Device Sales by Manufacturer
3.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Active Transdermal Drug Delivery Device Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Active Transdermal Drug Delivery Device
3.4 Market Concentration Rate
3.4.1 Top 3 Active Transdermal Drug Delivery Device Manufacturer Market Share
3.4.2 Top 6 Active Transdermal Drug Delivery Device Manufacturer Market Share
3.5 Global Active Transdermal Drug Delivery Device Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Active Transdermal Drug Delivery Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Active Transdermal Drug Delivery Device Market Size by Region
4.1.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Region (2016-2026)
4.1.2 Global Active Transdermal Drug Delivery Device Revenue by Region (2016-2026)
4.2 North America Active Transdermal Drug Delivery Device Revenue (2016-2026)
4.3 Europe Active Transdermal Drug Delivery Device Revenue (2016-2026)
4.4 Asia-Pacific Active Transdermal Drug Delivery Device Revenue (2016-2026)
4.5 South America Active Transdermal Drug Delivery Device Revenue (2016-2026)
4.6 Middle East and Africa Active Transdermal Drug Delivery Device Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Type (2016-2026)
5.2 Global Active Transdermal Drug Delivery Device Revenue by Type (2016-2026)
5.3 Global Active Transdermal Drug Delivery Device Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Application (2016-2026)
6.2 Global Active Transdermal Drug Delivery Device Revenue by Application (2016-2026)
6.3 Global Active Transdermal Drug Delivery Device Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Active Transdermal Drug Delivery Device Sales by Type (2016-2026)
7.2 North America Active Transdermal Drug Delivery Device Sales by Application (2016-2026)
7.3 North America Active Transdermal Drug Delivery Device Market Size by Country
7.3.1 North America Active Transdermal Drug Delivery Device Sales in Volume by Country (2016-2026)
7.3.2 North America Active Transdermal Drug Delivery Device Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Active Transdermal Drug Delivery Device Sales by Type (2016-2026)
8.2 Europe Active Transdermal Drug Delivery Device Sales by Application (2016-2026)
8.3 Europe Active Transdermal Drug Delivery Device Market Size by Country
8.3.1 Europe Active Transdermal Drug Delivery Device Sales in Volume by Country (2016-2026)
8.3.2 Europe Active Transdermal Drug Delivery Device Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Active Transdermal Drug Delivery Device Sales by Type (2016-2026)
9.2 Asia-Pacific Active Transdermal Drug Delivery Device Sales by Application (2016-2026)
9.3 Asia-Pacific Active Transdermal Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Active Transdermal Drug Delivery Device Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Active Transdermal Drug Delivery Device Sales by Type (2016-2026)
10.2 South America Active Transdermal Drug Delivery Device Sales by Application (2016-2026)
10.3 South America Active Transdermal Drug Delivery Device Market Size by Country
10.3.1 South America Active Transdermal Drug Delivery Device Sales in Volume by Country (2016-2026)
10.3.2 South America Active Transdermal Drug Delivery Device Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type (2016-2026)
11.2 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application (2016-2026)
11.3 Middle East & Africa Active Transdermal Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Active Transdermal Drug Delivery Device Typical Distributors
12.3 Active Transdermal Drug Delivery Device Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Active Transdermal Drug Delivery Device Revenue by Type, (USD Million), 2021-2026
Table 2. Global Active Transdermal Drug Delivery Device Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Active Transdermal Drug Delivery Device Product and Services
Table 6. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Noven Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Noven Pharmaceuticals, Inc. Major Business
Table 9. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 10. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Transdermal Corp. Basic Information, Manufacturing Base and Competitors
Table 12. Transdermal Corp. Major Business
Table 13. Transdermal Corp. Active Transdermal Drug Delivery Device Product and Services
Table 14. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business
Table 17. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product and Services
Table 18. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 20. Mylan N.V. Major Business
Table 21. Mylan N.V. Active Transdermal Drug Delivery Device Product and Services
Table 22. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. 3M Basic Information, Manufacturing Base and Competitors
Table 24. 3M Major Business
Table 25. 3M Active Transdermal Drug Delivery Device Product and Services
Table 26. 3M Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Actavis, Inc. Major Business
Table 29. Actavis, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 30. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 32. Bayer AG Major Business
Table 33. Bayer AG Active Transdermal Drug Delivery Device Product and Services
Table 34. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim GmbH Major Business
Table 37. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product and Services
Table 38. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Corium International, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Corium International, Inc. Major Business
Table 41. Corium International, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 42. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Echo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Echo Therapeutics, Inc. Major Business
Table 45. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 46. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 48. GlaxoSmithKline plc Major Business
Table 49. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product and Services
Table 50. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Active Transdermal Drug Delivery Device Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Active Transdermal Drug Delivery Device Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Active Transdermal Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Active Transdermal Drug Delivery Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Active Transdermal Drug Delivery Device Production Site of Key Manufacturer
Table 56. Active Transdermal Drug Delivery Device New Entrant and Capacity Expansion Plans
Table 57. Active Transdermal Drug Delivery Device Mergers & Acquisitions in the Past Five Years
Table 58. Global Active Transdermal Drug Delivery Device Sales by Region (2016-2021e) & (K Units)
Table 59. Global Active Transdermal Drug Delivery Device Sales by Region (2021-2026) & (K Units)
Table 60. Global Active Transdermal Drug Delivery Device Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Active Transdermal Drug Delivery Device Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 63. Global Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 64. Global Active Transdermal Drug Delivery Device Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Active Transdermal Drug Delivery Device Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Active Transdermal Drug Delivery Device Price by Type (2016-2021e) & (USD/Unit)
Table 67. Global Active Transdermal Drug Delivery Device Price by Type (2021-2026) & (USD/Unit)
Table 68. Global Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 69. Global Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 70. Global Active Transdermal Drug Delivery Device Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Active Transdermal Drug Delivery Device Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Active Transdermal Drug Delivery Device Price by Application (2016-2021e) & (USD/Unit)
Table 73. Global Active Transdermal Drug Delivery Device Price by Application (2021-2026) & (USD/Unit)
Table 74. North America Active Transdermal Drug Delivery Device Sales by Country (2016-2021e) & (K Units)
Table 75. North America Active Transdermal Drug Delivery Device Sales by Country (2021-2026) & (K Units)
Table 76. North America Active Transdermal Drug Delivery Device Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Active Transdermal Drug Delivery Device Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 79. North America Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 80. North America Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 81. North America Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 82. Europe Active Transdermal Drug Delivery Device Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Active Transdermal Drug Delivery Device Sales by Country (2021-2026) & (K Units)
Table 84. Europe Active Transdermal Drug Delivery Device Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Active Transdermal Drug Delivery Device Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 88. Europe Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 98. South America Active Transdermal Drug Delivery Device Sales by Country (2016-2021e) & (K Units)
Table 99. South America Active Transdermal Drug Delivery Device Sales by Country (2021-2026) & (K Units)
Table 100. South America Active Transdermal Drug Delivery Device Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Active Transdermal Drug Delivery Device Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 103. South America Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 104. South America Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 105. South America Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Active Transdermal Drug Delivery Device Typical Distributors
Table 117. Active Transdermal Drug Delivery Device Typical Customers
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Picture
Figure 2. Global Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 3. Patches
Figure 4. Gels
Figure 5. Global Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Home Use
Figure 9. Global Active Transdermal Drug Delivery Device Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Active Transdermal Drug Delivery Device Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Active Transdermal Drug Delivery Device Sales (2016-2026) & (K Units)
Figure 12. Global Active Transdermal Drug Delivery Device Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Active Transdermal Drug Delivery Device Production Capacity (2016-2026) & (K Units)
Figure 14. Global Active Transdermal Drug Delivery Device Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Active Transdermal Drug Delivery Device Market Drivers
Figure 16. Active Transdermal Drug Delivery Device Market Restraints
Figure 17. Active Transdermal Drug Delivery Device Market Trends
Figure 18. Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturer in 2020
Figure 19. Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturer in 2020
Figure 20. Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Active Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Active Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2016-2026)
Figure 24. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2016-2026)
Figure 25. North America Active Transdermal Drug Delivery Device Revenue (2016-2026) & (USD Million)
Figure 26. Europe Active Transdermal Drug Delivery Device Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Active Transdermal Drug Delivery Device Revenue (2016-2026) & (USD Million)
Figure 28. South America Active Transdermal Drug Delivery Device Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Active Transdermal Drug Delivery Device Revenue (2016-2026) & (USD Million)
Figure 30. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2026)
Figure 31. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2016-2026)
Figure 32. Global Active Transdermal Drug Delivery Device Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 34. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2016-2026)
Figure 35. Global Active Transdermal Drug Delivery Device Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2026)
Figure 37. North America Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 38. North America Active Transdermal Drug Delivery Device Sales Market Share by Country (2016-2026)
Figure 39. North America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2016-2026)
Figure 40. United States Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2026)
Figure 44. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 45. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2016-2026)
Figure 46. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2016-2026)
Figure 47. Germany Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Region (2016-2026)
Figure 56. China Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2026)
Figure 63. South America Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 64. South America Active Transdermal Drug Delivery Device Sales Market Share by Country (2016-2026)
Figure 65. South America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Active Transdermal Drug Delivery Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
アクティブ経皮ドラッグデリバリーデバイス市場：世界及び中国市場分析・予測（～2024年） Active Transdermal Drug Delivery Device Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Active Transdermal Drug Delivery Device industry with a focus on the Chinese market. The report provides key statistics on the market stat…- 世界の経皮および経粘膜薬物送達市場予測（～2024年）：企業別、地域別、種類・用途別 When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results. Scope of the Report: The global Transdermal and Transmucosal Drug Delivery market is valued at xx million USD in 2018 and is expected…
- 世界の経皮ドラッグデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Transdermal Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の経皮パッチドラッグデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Transdermal Patch Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の経皮/経粘膜ドラッグデリバリーシステム市場予測（～2024年） Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products. …